Clinical Trials in Brazil / NCT05729009
Recruiting Observational

The Evolution of Systemic Microvascular Reactivity in Heart Transplant Patients

NCT05729009 · tracked via the Priya Life Science Brazil tracker
Phase
Observational
Started
2022-10-01
Last updated
2026-04-13

Condition(s) studied

Heart Transplantation

Investigational drug(s) / intervention(s)

skin microvascular reactivity

skin microvascular reactivity: Laser-based method for evaluating non-invasive, operator-independent systemic microvascular function that detects microvascular flow in the skin for the evaluation of systemic vascular endothelial function.

Study summary

The evolution of systemic microvascular reactivity may aid in the comprehension of cardiovascular physiology in heart transplantation patients, and possibly suggest the non-invasive evaluation of skin microcirculation as an ancillary tool in the clinical evaluation of these patients.

Eligibility

Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: * capability to understand the objectives of the research and to fulfill the Term of Consent Exclusion Criteria: * Pregnancy, acute infection diagnosis, use of circulatory assistance devices

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Eduardo Tibiriçá Rio de Janeiro Brazil Recruiting

More National Institute of Cardiology, Laranjeiras, Brazil trials in Brazil

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05729009 on ClinicalTrials.gov ↗ ← All trials in Brazil